ASIA PACIFIC PAIN MANAGEMENT DRUGS MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • ASIA PACIFIC PAIN MANAGEMENT DRUGS MARKET FORECAST 2019-2027

ASIA PACIFIC PAIN MANAGEMENT DRUGS MARKET FORECAST 2019-2027

Pain management drugs market in the Asia Pacific region has been on a tremendous rise, quantified at 4.73% CAGR from 2019 to 2027. The approach for pain management mainly involves the reduction or treatment of pain using a particular set of drugs. Various drugs are available, which provides pain relief through many physiological mechanisms, for instance, by targeting the nociceptors. There has been a surge in the frequency of chronic diseases like diabetic neuropathy and osteoarthritis that has been propelling the market growth.

ASIA PACIFIC PAIN MANAGEMENT DRUGS MARKET FORECAST 2019-2027

Asia Pacific Pain Management Drugs Market by Drug Class (Nsaids, Anesthetics, Anticonvulsants, Anti-migraine Agents, Antidepressants, Opioids, Non-narcotic Analgesics), Market by (Indication, Arthriticpain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Post-operative Pain, Migraine, Fibromyalgia) & by Geography.

Request free sample

Pain management drugs market in the Asia Pacific region has been on a tremendous rise, quantified at 4.73% CAGR from 2019 to 2027. The approach for pain management mainly involves the reduction or treatment of pain using a particular set of drugs. Various drugs are available, which provides pain relief through many physiological mechanisms, for instance, by targeting the nociceptors. There has been a surge in the frequency of chronic diseases like diabetic neuropathy and osteoarthritis that has been propelling the market growth. The APAC region has a humongous patient pool, and there has been an increase in healthcare expenditure that is also driving the pain management market growth.

The major countries whose market has been contributing revenue to the global market are that of China, India, Japan, Australia, South Korea and the collective countries from the Rest of Asia Pacific. The APAC regional market is the fastest growing one across the world since comprising countries like Japan pain management drugs market has been integral to the market growth; the nation is the largest revenue contributor. This can be attributable to the soaring cancer rates and the aging population in the nation. Moreover, the growing prevalence of chronic pain and high unmet needs among the customer base in Japan are also significant for the market growth in the region.

The companies reaping huge revenues in the APAC region for pain management drugs market are Purdue Pharma L.P., Novartis, Daiichi Sankyo, Inc., Egalet Corp., Eli Lilly and Company, Insys Therapeutics, Inc., GlaxoSmithKline, Abbott Laboratories, Hikma Pharmaceuticals PLC, Johnson & Johnson, Lupin Ltd., Pfizer, Inc., Merck & Co., Inc., Cipher Pharmaceuticals Inc. and Acura Pharmaceuticals, Inc.

 

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • OPIOIDS MARKET HOLDS THE LARGEST MARKET SHARE IN TERMS OF DRUG CLASS
      • CANCER PAIN INDICATION IS ANTICIPATED TO GROW AT A SIGNIFICANT RATE
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • GROWTH IN THE INCIDENCE AND PREVALENCE OF CHRONIC DISEASES
      • THE RISE IN AWARENESS REGARDING THE SIDE-EFFECTS OF PAIN MEDICATION
      • RISE IN GERIATRIC POPULATION
    • MARKET RESTRAINTS
      • ACCESSIBILITY OF ALTERNATIVE THERAPIES
      • INCREASE IN DRUG MISTREATMENT
    • MARKET OPPORTUNITIES
      • TECHNOLOGICAL ADVANCEMENT
      • GROWTH POTENTIAL IN UNTAPPED ECONOMIES
    • MARKET CHALLENGES
      • PATENT EXPIRATION
  1. MARKET BY DRUG CLASS
    • NSAIDS
    • ANESTHETICS
    • ANTICONVULSANTS
    • ANTI-MIGRAINE AGENTS
    • ANTIDEPRESSANTS
    • OPIOIDS
    • NON-NARCOTIC ANALGESICS
  2. MARKET BY INDICATION
    • ARTHRITIC PAIN
    • NEUROPATHIC PAIN
    • CANCER PAIN
    • CHRONIC BACK PAIN
    • POST-OPERATIVE PAIN
    • MIGRAINE
    • FIBROMYALGIA
  3. KEY ANALYTICS
    • PORTER’S FIVE FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • THREAT OF COMPETITIVE RIVALRY
    • REGULATORY FRAMEWORK
    • OPPORTUNITY MATRIX
    • VALUE CHAIN ANALYSIS
    • VENDOR LANDSCAPE
  4. GEOGRAPHICAL ANALYSIS
    • ASIA-PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA-PACIFIC
  1. COMPETITIVE LANDSCAPE
    • MARKET SHARE ANALYSIS
    • COMPANY PROFILES
      • ABBOTT LABORATORIES
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • ACURA PHARMACEUTICALS, INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • CIPHER PHARMACEUTICALS INC.
        • COMPANY PROFILES
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • DAIICHI SANKYO, INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • EGALET CORP.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • ELI LILLY AND COMPANY
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • GLAXOSMITHKLINE
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • HIKMA PHARMACEUTICALS PLC
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • JOHNSON & JOHNSON
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • LUPIN LTD.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • PFIZER, INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • PURDUE PHARMA L.P.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • MERCK & CO., INC.
        • COMPANY PROFILES
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • NOVARTIS
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • INSYS THERAPEUTICS, INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES

TABLE LIST

TABLE  1      ASIA PACIFIC PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

TABLE  2      ASIA PACIFIC PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)

TABLE  3      ASIA PACIFIC NSAIDS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  4      ASIA PACIFIC ANESTHETICS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  5      ASIA PACIFIC ANTICONVULSANTS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  6      ASIA PACIFIC ANTI-MIGRAINE AGENTS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  7      ASIA PACIFIC ANTIDEPRESSANTS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  8      ASIA PACIFIC OPIOIDS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  9      ASIA PACIFIC NON-NARCOTIC ANALGESICS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  10    ASIA PACIFIC PAIN MANAGEMENT DRUGS MARKET BY INDICATION 2019-2027 ($ MILLION)

TABLE  11    ASIA PACIFIC ARTHRITIC PAIN MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  12    ASIA PACIFIC NEUROPATHIC PAIN MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  13    ASIA PACIFIC CANCER PAIN MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  14    ASIA PACIFIC CHRONIC BACK PAIN MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  15    ASIA PACIFIC POST-OPERATIVE PAIN MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  16    ASIA PACIFIC MIGRAINE MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  17    ASIA PACIFIC FIBROMYALGIA MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  18    ASIA PACIFIC PAIN MANAGEMENT DRUGS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  19    ASIA-PACIFIC PAIN MANAGEMENT DRUGS MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE  20    JAPAN PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)

TABLE  21    JAPAN PAIN MANAGEMENT DRUGS MARKET BY INDICATION  2019-2027 ($ MILLION)

TABLE  22    CHINA PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)

TABLE  23    CHINA PAIN MANAGEMENT DRUGS MARKET BY INDICATION  2019-2027 ($ MILLION)

TABLE  24    INDIA PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)

TABLE  25    INDIA PAIN MANAGEMENT DRUGS MARKET BY INDICATION  2019-2027 ($ MILLION)

TABLE  26    AUSTRALIA PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)

TABLE  27    AUSTRALIA PAIN MANAGEMENT DRUGS MARKET BY INDICATION  2019-2027 ($ MILLION)

TABLE  28    SOUTH KOREA PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)

TABLE  29    SOUTH KOREA PAIN MANAGEMENT DRUGS MARKET BY INDICATION  2019-2027 ($ MILLION)

FIGURE LIST

FIGURE  1    ASIA PACIFIC PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE  2    ASIA PACIFIC PAIN MANAGEMENT DRUGS MARKET SHARE BY DRUG CLASS 2018 & 2027 (%)

FIGURE  3    ASIA PACIFIC PAIN MANAGEMENT DRUGS MARKET BY NSAIDS 2019-2027 ($ MILLION)

FIGURE  4    ASIA PACIFIC PAIN MANAGEMENT DRUGS MARKET BY ANESTHETICS 2019-2027 ($ MILLION)

FIGURE  5    ASIA PACIFIC PAIN MANAGEMENT DRUGS MARKET BY ANTICONVULSANTS 2019-2027 ($ MILLION)

FIGURE  6    ASIA PACIFIC PAIN MANAGEMENT DRUGS MARKET BY ANTI-MIGRAINE AGENTS 2019-2027 ($ MILLION)

FIGURE  7    ASIA PACIFIC PAIN MANAGEMENT DRUGS MARKET BY ANTIDEPRESSANTS 2019-2027 ($ MILLION)

FIGURE  8    ASIA PACIFIC PAIN MANAGEMENT DRUGS MARKET BY OPIOIDS 2019-2027 ($ MILLION)

FIGURE  9    ASIA PACIFIC PAIN MANAGEMENT DRUGS MARKET BY NON-NARCOTIC ANALGESICS 2019-2027 ($ MILLION)

FIGURE  10  ASIA PACIFIC PAIN MANAGEMENT DRUGS MARKET SHARE BY INDICATION 2018 & 2027 (%)

FIGURE  11  ASIA PACIFIC PAIN MANAGEMENT DRUGS MARKET BY ARTHRITIC PAIN 2019-2027 ($ MILLION)

FIGURE  12  ASIA PACIFIC PAIN MANAGEMENT DRUGS MARKET BY NEUROPATHIC PAIN 2019-2027 ($ MILLION)

FIGURE  13  ASIA PACIFIC PAIN MANAGEMENT DRUGS MARKET BY CANCER PAIN 2019-2027 ($ MILLION)

FIGURE  14  ASIA PACIFIC PAIN MANAGEMENT DRUGS MARKET BY CHRONIC BACK PAIN 2019-2027 ($ MILLION)

FIGURE  15  ASIA PACIFIC PAIN MANAGEMENT DRUGS MARKET BY POST-OPERATIVE PAIN 2019-2027 ($ MILLION)

FIGURE  16  ASIA PACIFIC PAIN MANAGEMENT DRUGS MARKET BY MIGRAINE 2019-2027 ($ MILLION)

FIGURE  17  ASIA PACIFIC PAIN MANAGEMENT DRUGS MARKET BY FIBROMYALGIA 2019-2027 ($ MILLION)

FIGURE  18  PORTER’S FIVE FORCE MODEL

FIGURE  19  ASIA PACIFIC PAIN MANAGEMENT DRUGS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)

FIGURE  20  JAPAN PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE  21  CHINA PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE  22  INDIA PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE  23  AUSTRALIA PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE  24  SOUTH KOREA PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE  25  REST OF ASIA-PACIFIC PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE  26  PAIN MANAGEMENT MARKET SHARE ANALYSIS 2017 (%)

  1. GEOGRAPHICAL ANALYSIS
    • ASIA-PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA-PACIFIC
  1. MARKET BY DRUG CLASS
    • NSAIDS
    • ANESTHETICS
    • ANTICONVULSANTS
    • ANTI-MIGRAINE AGENTS
    • ANTIDEPRESSANTS
    • OPIOIDS
    • NON-NARCOTIC ANALGESICS
  2. MARKET BY INDICATION
    • ARTHRITIC PAIN
    • NEUROPATHIC PAIN
    • CANCER PAIN
    • CHRONIC BACK PAIN
    • POST-OPERATIVE PAIN
    • MIGRAINE
    • FIBROMYALGIA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now